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In this study we have assessed the effects of increased cortisol levels during early
embryonic development on immune function in zebrafish (Danio rerio) larvae. Fertilized
eggs were exposed to either a cortisol-containing, a dexamethasone-containing
(to stimulate the glucocorticoid receptor selectively) or a control medium for 6 h
post-fertilization (0–6 hpf). First, we measured baseline expression of a number of
immune-related genes (socs3a, mpeg1.1, mpeg1.2, and irg1l) 5 days post-fertilization
(dpf) in larvae of the AB and TL strain to assess the effectiveness of our exposure
procedure and potential strain differences. Cortisol and dexamethasone strongly
up-regulated baseline expression of these genes independent of strain. The next series
of experiments were therefore carried out in larvae of the AB strain only. We measured
neutrophil/macrophage recruitment following tail fin amputation (performed at 3 dpf)
and phenotypical changes as well as survival following LPS-induced sepsis (150µg/ml;
4–5 dpf). Dexamethasone, but not cortisol, exposure at 0–6 hpf enhanced neutrophil
recruitment 4 h post tail fin amputation. Cortisol and dexamethasone exposure at
0–6 hpf led to a milder phenotype (e.g., less tail fin damage) and enhanced survival
following LPS challenge compared to control exposure. Gene-expression analysis
showed accompanying differences in transcript abundance of tlr4bb, cxcr4a, myd88,
il1β, and il10. These data show that early-life exposure to cortisol, which may be
considered to be a model or proxy of maternal stress, induces an adaptive response
to immune challenges, which seems mediated via the glucocorticoid receptor.
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INTRODUCTION
In teleosts, like zebrafsh (Danio rerio), cortisol is the main endogenous corticosteroid, which is
secreted when individuals perceive situations as stressful (1). Like in other vertebrate species,
cortisol binds in teleosts to the mineralocorticoid receptor (MR) and the glucocorticoid receptor
(GR), which affects the transcription rates of genes following ligand binding (2–4). Since the
GR has a lower affinity for cortisol than the MR, the GR mediates the actions of cortisol during
stress, which involves optimizing energy expenditure by tuning the balance between and within
physiological systems, like an organism’s metabolism and its immune, cardiovascular and central
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nervous system [e.g., (1, 4, 5)]. Following long-term exposure
to stress, baseline levels of cortisol are increased, reflecting the
allostatic load that the environment imposes on an organism
(5, 6). Cortisol has been shown to signal through the GR
already during the very early stages of embryonic development;
in oocytes maternally deposited cortisol and GR mRNA are
present (7–9). These cortisol levels may reflect the allostatic
load that the mothers experience in their environment and it
has therefore been hypothesized that these deposited cortisol
levels are important for preparing the offspring for the expected
allostatic load that larvae will encounter in the prevailing
environment, thereby programming their cortisol secretion and
the functioning of physiological systems to meet expected
demands (4, 10). While in previous studies we focussed on the
effects of cortisol exposure [between 0 and 6 h post fertilization
(hpf)] on vigilance-related behavior, baseline cortisol levels and
metabolism in larvae (10, 11) in the present study we focussed on
the functioning of the immune system, in particular the innate
immune system on which zebrafish larvae rely (12). Cortisol
exposure may be considered to be a model or proxy of maternal
stress (10, 13–15).
Zebrafish is a highly suitable animal model to study early
life events in the fields of biomedical research, behavioral
biology and eco-toxicology [e.g., (4, 16–19)]. Fertilized eggs
develop into independently feeding larvae outside the mother,
without parental care, and can easily be maintained under
different experimental conditions as well as pharmacologically
manipulated. In zebrafish, it has been demonstrated that mothers
deposit cortisol and GR mRNA in oocytes (7–9). These cortisol
levels decrease over the first 24 h post fertilization, after which
zygotes gradually start to produce cortisol by the then developing
interrenal cells (7–9, 20). After hatching (48–72 hpf) pituitary
control over interrenal cortisol production starts and it takes
another 4–5 days before the hypothalamus-pituitary-interrenal
(HPI) axis is fully functionally mature (2, 3). Maternal GRmRNA
is present during the first 6 hpf, and at 8–9 hpf zygotic expression
of the GR commences, while the MR mRNA production starts at
24 hpf (3, 7, 8).
In several studies the effect of cortisol exposure during early
embryonic stages has been investigated in zebrafish. In these
studies cortisol levels were increased by injection of cortisol into
the yolk of one-cell stage embryos [e.g., (13–15)] or through
addition of cortisol to the medium (10, 21). These studies showed
that, as a result of the cortisol exposure during early embryonic
stages, larval baseline levels of cortisol were increased (10, 13,
14, 21). For example, in a recent study, we have demonstrated
that cortisol exposure between 0 and 6 hpf increased baseline
cortisol levels 5 days post fertilization (dpf) of larvae from the
AB strain (10).
Abbreviations: ANOVA, analysis of variance; dpf, days post-fertilization;
GFP, green fluorescent protein; GR, glucocorticoid receptor; hpa, hours
post-amputation; hpf, hours post-fertilization; HPI-axis, hypothalamus –
pituitary - interrenal axis; IL, interleukine; KMO, Kaiser-Meyer-Olkin;
LPS, lipopolysaccharide; MANOVA, multivariate analysis of variance; MR,
mineralocorticoid receptor; ns, not significant; PBS, phosphate buffered saline;
qPCR, quantitative polymerase chain reaction; SEM, standard error of the mean;
TLR, Toll-like receptor; Tukey HSD, Tukey Honestly Significant Difference.
Exposure to cortisol (0–5 dpf) has been shown to lead to an
enhanced expression of immune-related genes in zebrafish larvae
at 5 dpf (21), suggesting that early cortisol exposure increases
the activity of the immune system. In the present study, we
have first measured the expression of a selected number of these
up-regulated genes at 5 dpf (socs3a, mpeg1.1, mpeg1.2, irg1l)
following our 0–6 hpf exposure to cortisol (10) in zebrafish larvae
of the AB strain to assess whether our method produces similar
effects. Tüpfel long-fin (TL) is another widely used zebrafish
strain next to AB and is characterized by spots rather than
stripes as well as long fins rather than short fins. In previous
studies we have observed consistent differences between larvae
of the AB strain and larvae of the TL strain at the level of both
HPI-axis activity and behavior (10, 22–24). We have attributed
these differences to the mutation in the connexin 41.8 gene
that leads to spots [for discussion: see (24)]. Measuring the
expression of these genes in larvae of the TL strain next to larvae
in the AB strain may therefore reveal how robust our findings
are. Finally, to assess the role of the GR in more detail, we
exposed fertilized eggs 0–6 hpf to dexamethasone, a specific GR
agonist (25).
To functionally assess the activity of the immune system
following early life exposure to cortisol or dexamethasone, we
used two experimental models for immune activation. First,
we used the tail fin amputation assay. This is a well-established
model in which amputation of the tail triggers expression
of many pro-inflammatory molecules and the recruitment
of innate immune cells (neutrophils and macrophages)
toward the wounded area (26–28). The tail fin amputation
assay was performed using the double transgenic fish line
Tg(mpx:GFP/mpeg1:mCherry-F) (27, 29). Recruitment of
neutrophils and macrophages was determined following tail
fin amputation in larvae at 3 dpf (30, 31). Second, we used a
sepsis model, which involved a challenge with lipopolysaccharide
(LPS), the membrane component of Gram-negative bacteria,
in 4 dpf larvae. We measured survival, phenotypical
changes, and the expression of a series of LPS-responsive
genes (32–35).
MATERIALS AND METHODS
Subjects, Spawning, and Care
Housing conditions and breeding procedures were similar as
those reported in Van den Bos et al. (10, 22, 23), AB and Tüpfel
long-fin (TL) strains, or Xie et al. (31), the double transgenic
fish line Tg(mpx:GFP/mpeg1:mCherry-F). They were kept in
recirculation systems (∼28◦C) under a 14:10 h light-dark cycle
and fed twice daily.
Breeding started at least 1 h after the last feeding of zebrafish
(>16:00 h). Males and females of the AB or TL strain were placed
in a zebrafish breeding tank, separated by a partitioning wall, with
water of∼28◦C. After turning on the lights the next morning, the
partitioning wall was removed and tanks were placed at a slight
angle, such that the fish had the possibility to move into shallow
water to spawn.
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Cortisol/Dexamethasone Exposure During
Early Embryonic Development (0–6 hpf)
Cortisol (hydrocortisone; Sigma-Aldrich, Zwijndrecht, the
Netherlands) and dexamethasone (Sigma-Aldrich, Zwijndrecht,
the Netherlands) were dissolved in 96% ethanol in the required
stock solution concentrations and stored at −20◦C. From
these stock solutions media with the appropriate concentration
were freshly prepared for each experiment (10, 36): cortisol-
containing medium: 400 µg/l cortisol (1.1µM), 0.4 ml/l 96%
ethanol (0.04% v/v), 5mM NaCl, 0.17mM KCl, 0.33mM
CaCl2, 0.33mM MgSO4 in dH2O; dexamethasone-containing
medium: 430 µg/l dexamethasone (1.1µM), 0.4 ml/l 96%
ethanol [or 1 ml/l 96% ethanol (0.1% v/v); depending on the
specific experiment], 5mM NaCl, 0.17mM KCl, 0.33mM CaCl2,
0.33mM MgSO4 in dH2O. Control medium consisted of: 0.4
ml/l 96% ethanol (or 1 ml/l 96% ethanol; depending on the
specific experiment), 5mM NaCl, 0.17mM KCl, 0.33mM CaCl2,
0.33mMMgSO4 in dH2O.
For each experiment we used between 8 and 12 breeding trios
(one female and two males). Directly following each spawning
and fertilization, eggs were collected and randomly assigned
to Petri dishes filled with either cortisol-containing medium,
dexamethasone-containing medium or control medium. Thus,
for each treatment we had multiple Petri dishes with eggs
from all breeding pairs. Within 1–1.5 hpf Petri dishes were
placed in an incubator set at 28.5◦C (300–350 lux). Eggs
were exposed to these solutions for 6 hrs. It has been
shown that both cortisol and dexamethasone diffuse inside
the eggs in this period (37). In addition, we have already
shown in earlier studies that this procedure is effective in
eliciting changes in physiology and behavior at 3–5 dpf (10,
36).
Following this, cortisol-containing, dexamethasone-
containing and control media were replaced by E3 medium
(5mM NaCl, 0.17mM KCl, 0.33mM CaCl2, 0.33mM MgSO4,
3 ml/l 0.01% (w/v) methylene blue in dH2O). Embryos
were rinsed twice in E3 medium to ensure that the original
treatment media were completely removed. Petri dishes
were returned to the incubator allowing the embryos to
develop further (28.5◦C; 14:10 h light-dark period (lights on:
09.00–23.00 h); light phase: 300–350 lux; dark phase; 0 lux).
At 1 and 4 dpf E3 medium was refreshed and unfertilized
eggs, dead eggs/embryos/larvae and chorions were removed
from the dishes.
All experiments were carried out in accordance with the
Dutch Experiments on Animals Act (http://wetten.overheid.nl/
BWBR0003081/2014-12-18), the European guidelines for animal
experiments (Directive 2010/63/EU; http://eur-lex.europa.
eu/legal-content/NL/TXT/HTML/?uri=CELEX:32010L0063)
and institutional regulations (Radboud University or Leiden
University). Larvae were euthanized by placing them in ice
slurry for at least 20min followed by adding bleach to the slurry.
In case of anesthesia 0.01% 2-phenoxyethanol (Sigma Aldrich,
Zwijndrecht, the Netherlands; experiments Radboud University)
or 0.02% buffered aminobenzoic acid ethyl ester (tricaine; Sigma
Aldrich, Zwijndrecht, the Netherlands; experiments Leiden
University) was used.
Baseline Gene Expression Analysis
Following 0–6 hpf to the different media, larvae of the AB and TL
strain were sampled for gene expression at 5 dpf between 16.00
and 19.00 h in line with our earlier study [(10); experimental
time-line Figure 1]. Genes of interest were: socs3a, mpeg1.1,
mpeg1.2, and irg1l [for primer sequences of these genes: see
(22)]. Gene expression was determined by qPCR analysis as
described below.
Tail Fin Amputation Assay
The tail fin amputation assay was performed using the
double transgenic fish line Tg [mpx:GFP/mpeg1:mCherry-F;
(27, 29)]. Three-day-old zebrafish larvae were anesthetized in
E3 medium containing 0.02% buffered tricaine and loaded
onto 2% agarose-coated Petri dishes (experimental time-line:
Figure 1). Amputation was performed with a 1mm sapphire
blade (World Precision Instruments, Friedberg, Germany) using
a Leica M165C stereomicroscope and a micromanipulator (Leica
Microsystems BV, Amsterdam, the Netherlands; see below,
Figure 3). Larvae were fixed in 4% paraformaldehyde in PBS
at 4 h post amputation (hpa) and stored overnight at 4◦C. The
following day larvae were washed twice for 1min and then twice
for 5min in PBS containing 0.01% Tween 20 (Sigma Aldrich,
Zwijndrecht, the Netherlands).
A Leica M205FA fluorescence stereomicroscope supported
by LAS software (version 4.12.0; Leica Microsystems BV,
Amsterdam, the Netherlands) was utilized to visualize the
leukocytes. Detection of neutrophils and macrophages was based
on their fluorescent GFP and mCherry signals, respectively.
To quantify cell migration toward the wounded area, cells
within a distance of 200µm from the amputation site were
counted manually, as previously described (31). Data (numbers
of migrated neutrophils and macrophages per individual)
were pooled from three individual experiments (n > 10 per
experiment), and the presented data are means (± SEM).
LPS Exposure
First, we conducted a pilot study to assess the optimal LPS dose,
exposure duration and parameters to be measured [protocols
adapted from: (32–35)]. Incubation for 30min in 150µg/ml
LPS (B11.04; Sigma Aldrich, Zwijndrecht, the Netherlands) was
effective in eliciting a robust increase in il1β expression (assessed
using qPCR analysis), changes in tail fin morphology (swollen
or damaged tails) and increased levels of reactive oxygen species
[ROS; measured by a fluorescent labeling method according to
(35)]. Hence, we used this dose in subsequent experiments.
Subsequently, two experiments were conducted. In both
experiments 4 dpf larvae were exposed to 150µg/ml LPS (B11.04;
Sigma Aldrich, Zwijndrecht, the Netherlands) in E2 medium or
control E2 medium for 30min in Petri dishes (n = 50 in 25ml;
experimental time-line: Figure 1). Following this exposure, LPS-
containing medium or control E2 medium was replaced by
fresh E2 medium (larvae were rinsed two times to ensure that
the original media were removed). Larvae either remained in
the Petri dishes for sampling for gene expression at later time
points or were transferred individually to 24 wells plates (Greiner
Bio-One BV, Alphen a/d Rijn, the Netherlands) for assessing
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FIGURE 1 | Experimental time-line of the different experiments. dex, dexamethasone.
phenotypical changes and survival (volume per well: 1–1.5ml).
Six treatment groups were thus created: 0–6 hpf control, cortisol
or dexamethasone treatment, combined with either 4 dpf LPS or
control treatment (for 30 min).
In the first experiment the level of gene expression at 0,
0.5 h (i.e., directly following exposure), 1 hr (i.e., 30min after
ending exposure) and 3 h [i.e., 2.5 h after ending exposure; (34)]
was determined by qPCR analysis as described below. Genes of
interest [see papers by: (33–35, 38)] were genes encoding proteins
involved in barrier function of the vascular endothelium (cldn5a,
cldn2, oclnb), Toll-like receptors (tlr2, tlr4ba, tlr4bb, tlr5a, tlr5b),
and regulators of the immune response (il1β , il10,myd88, cxcr4a,
cxcr4b, ptpn6). Primer sequences are listed in Table 1.
In addition, in the first experiment survival and phenotypical
changes were determined at 0, 4 (i.e., 3.5 h after ending exposure)
and 28 h (i.e., 27.5 h after ending exposure). Phenotypical changes
included [see (35)]: changes in tail fin morphology (normal,
swollen (oedema) or damaged), presence of heart oedema and
changes in shape (straight or curved). In the second experiment
(that also served as replicate for the first experiment) survival and
phenotypical changes were measured at 0, 0.5, 1, 3, 6, and 24 h
(i.e., before exposure, directly after exposure, 0.5 h after ending
exposure, 2.5 h after ending exposure, 5.5 h after ending exposure
and 23.5 h after ending exposure).
Gene Expression Analysis
For the assessment of gene expression levels by qPCR analysis,
3–5 larvae were transferred to a 2-ml Eppendorf tube; thus,
one sample contained material from 3 to 5 larvae. Residual
medium was removed with a pipette, tubes were snap frozen in
liquid nitrogen, kept on ice during the sampling procedure, and
subsequently stored at−80◦C until total RNA extraction.
RNA isolation, RNA preparation, removal of genomic DNA
from the samples and synthesis of cDNA was performed
according to the protocol described in Van den Bos et al. (22).
Total RNA content of each sample was isolated. This was done by
homogenizing the tissue with 400 µl Trizol reagent (Invitrogen,
Carlsbad, USA) in a Grinding Mill (Retsch GmbH, Germany)
for 20 s at 20Hz. After homogenisation, samples were kept at
room temperature for 5min. Next, 80 µl chloroform was added
and the solution was mixed by shaking for 15 s. Afterwards,
samples were kept at room temperature for 2min. The samples
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Reference genes: elongation factor 1α (elf1α); ribosomal protein L13 (rpl13).
were centrifuged at 14,000 rpm for 10min in a cooled centrifuge
(4◦C) and the aqueous phase of the samples was transferred
to a new tube. To this phase, 200 µl isopropanol was added
and this solution was mixed well by inversion of the tube.
The solution was then stored at−20◦C for 2 h and centrifuged
afterwards for 15min at 14,000 rpm in a cooled centrifuge
(4◦C). The supernatant was decanted and the pellet washed
with 500 µl 75% ethanol and centrifuged 10min at 14,000 rpm
in a cooled centrifuge (4◦C). The supernatant was decanted,
after which the pellet was centrifuged for 5 s to remove all the
remaining supernatant using a pipette. The pellet containing
the RNA was air-dried for 10min at room temperature and
afterwards dissolved in 100 µl ice cold DEPC-treated dH2O. To
this RNA solution, 10 µl 3M NaAc (pH 5.4) and 250 µl 100%
ethanol were added. The solution was mixed by inverting the
tube and samples were stored for 2 h at−20◦C. Subsequently,
the samples were centrifuged for 15min at 14,000 rpm in a
cooled centrifuge (4◦C), and the supernatant was decanted and
the pellet washed as described earlier. Finally, the RNA pellet
was dissolved in 15 µl DEPC-treated dH2O. The concentration
and quality of RNA in each sample were measured using a
nanodrop spectrophotometer at 260 nm wavelength (Nanodrop,
Wilmington, DE, USA).
Isolated RNA was treated with DNase to remove any
(genomic) DNA from the sample; 400 ng RNA was transferred
into a PCR strip, andDEPC-treated dH2Owas added to a volume
of 8µl. To this, 2µl of DNase mix was added, containing 1µl 10x
DNase I reaction buffer and 1 µl (1 U/µl) amplification grade
DNase I (both from Invitrogen, Carlsbad, USA). The resulting
mix was incubated for 15min at room temperature. Afterwards,
1 µl 25mM EDTA was added to stop the DNase reaction and
the reaction mix was incubated for 10min at 65◦C and returned
on ice.
After the DNase treatment, samples were used to synthesize
cDNA by the addition of 1 µl random primers (250 ng/µl), 1
µl 10mM dNTP mix, 4 µl 5 × 1st strand buffer, 1 µl 0.1M
DTT, 1 µl RNase inhibitor (10 U/µl), 0.5 µl Superscript II
(reverse transcriptase) (200 U/µl) (all from Invitrogen, Carlsbad,
USA) and 0.5 µl DEPC-treated dH2O. The resulting mix was
incubated for 10min at 25◦C for annealing of the primers and
then 50min at 42◦C for reverse transcription. Enzymes were
hereafter inactivated by incubating samples at 70◦C for 15min.
Finally, 80 µl dH2O was added to dilute the samples five times
for the qPCR reaction.
To measure the relative gene expression in each sample, real-
time qPCR was carried out for each gene of interest. For each
qPCR reaction, 16 µl PCR mix (containing 10 µl SYBR green
mix (2x) (BioRad, Hercules, USA), 0.6 µl forward and reverse
gene-specific primer (10µM) and 4.8 µl H2O) was added to
4 µl of cDNA. The qPCR reaction (3min 95◦C, 40 cycles of
15 s 95◦C and 1min 60◦C) was carried out using a CFX 96
(BioRad, Hercules, USA) qPCRmachine. Analysis of the data was
carried out using a normalization index of two reference genes
[viz. elongation factor alpha (elf1a) and ribosomal protein L13
(rpl13)] (39).
Statistics
For gene expression analyses, outliers were removed following
Grubb’s outlier test (p≤ 0.01).We explored the interrelationships
of transcript abundance levels using Principal Component
Analysis (PCA) with orthogonal rotation [Varimax rotation with
Kaiser normalization; see (23)]. In case of missing samples, data
were excluded list-wise. The number of retained components was
based on eigenvalues (>1) and visual inspection of the scree plot.
The Kaiser- Meyer-Olkin (KMO) measure of sampling adequacy
and Bartlett’s test of sphericity were done to ensure that data
obeyed analysis criteria; both are measures to assess whether the
correlation matrix is suited for factor analysis (40). Component
scores were saved and used for further statistical analysis. The
following component loading cut-off points were considered:
≤-0.600 or ≥0.600 (40, 41).
For the basal gene expression values a two-way or three-
way Analysis of Variance (ANOVA) was run with treatment,
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strain or batch (where applicable) as independent factors. In
the tail fin amputation assay a Student’s t-test was run on the
number of neutrophils or macrophages at 4 hpa comparing
0–6 hpf treatment groups (cortisol vs. control; dexamethasone
vs. control).
In the LPS exposure experiment, for gene expression a
multivariate analysis of variance (MANOVA)was run (to account
for multiple comparisons) followed by univariate analysis of
variance [0–6 hpf treatment and time as independent factors
followed by post-hoc testing (Tukey HSD)]. In addition per time
point a one-way ANOVA was run with 0–6 hpf treatment as
factor followed by post-hoc testing (Tukey HSD).
In the two LPS exposure experiments differences in survival
rate were assessed using the Kaplan-Meijer procedure (Log
Rank Mantel-Cox). Differences in phenotypical changes were
compared using Chi-square tests.
Significance was set at p ≤ 0.05 and trends are indicated (p
≤ 0.10) where appropriate; ns: not significant: p > 0.10. Unless
otherwise stated all p-values are two-tailed. All statistical analyses
were done using IBM SPSS version 23 (IBM, Armonk, NY, USA).
RESULTS
Baseline Gene Expression Analysis
Rather than analyzing transcript abundance of different genes
following glucocorticoid treatment (cortisol or dexamethasone,
0–6 hpf) separately, we explored the effects of exposure
through the interrelationships of transcript abundance of genes
using PCA.
A PCA for the 0–6 hpf cortisol treatment experiment revealed
two components (Figure 2A; Supplementary Figure 1A shows
the transcript abundance of individual genes). The KMO value
was sufficiently high (0.522) and Bartlett’s test of sphericity was
highly significant (Chi-square = 17.707, df = 6, p ≤0.007),
indicating that the data were adequate for a PCA. The first
component (explaining 44.0% of the variance) was comprised
of irg1l (loading: 0.854) and socs3a (loading: 0.890); the second
component (explaining 28.9% of the variance) of mpeg1.1
(loading: 0.890) and mpeg1.2 (loading: 0.890). Each component
was analyzed separately using ANOVA. Treatment (0–6 hpf) with
cortisol enhanced transcript abundance of genes in component
1 (irg1l and socs3a) independent of strain [three-way ANOVA
(strain, treatment, batch): treatment: F(1, 23) = 6.477, p ≤ 0.018].
Transcript abundance was overall higher in TL than AB larvae
[strain: F(1, 23) = 7.023, p ≤ 0.014]. Treatment (0–6 hpf) with
cortisol enhanced transcript abundance of genes in component
2 (mpeg1.1 and mpeg1.2) independent of strain [three-way
ANOVA (strain, treatment, batch): treatment: F(1, 23) = 7.660,
p ≤ 0.011].
A PCA for the 0–6 hpf dexamethasone treatment
experiment revealed only one component (Figure 2B;
Supplementary Figure 1B shows the transcript abundance
of individual genes). The KMO was sufficiently high (0.626) and
Bartlett’s test of sphericity was highly significant (Chi-square
= 102.945, df = 6, p < 0.001), indicating that the data were
adequate for a PCA. This component explained 76.6% of the
variance. Loadings onto this component were: irg1l (0.867).
FIGURE 2 | (A) Regression scores (mean ± SEM) of components 1 and 2
from the PCA for the different treatments (cortisol or control) and strains (AB or
TL). Genes that contributed to the components are indicated in the figure. One
subject was removed from the statistical analyses (TL control) as it was a
consistent outlier following Grubb’s outlier test. (B) Regression scores (mean ±
SEM) of the only component of the PCA for the different treatments
(dexamethasone or control) and strains (AB or TL). Genes that contributed to
the component are indicated in the figure.
socs3a (0.835), mpeg1.1 (0.928), and mpeg1.2 (0.868). Treatment
with dexamethasone enhanced transcript abundance of genes
independent of strain [two-way ANOVA (strain, treatment):
treatment: F(1, 33) = 6.745, p ≤ 0.014].
These data show that glucocorticoid treatment was effective
in eliciting changes in baseline expression of (a selected set of)
immune-related genes.
Tail Fin Amputation Assay
The inserts in Figure 3 show the site of the tail fin amputation
at 3 dpf. Neutrophil recruitment at 4 hpa was enhanced in the
0–6 hpf dexamethasone treatment group (Student’s t-test: t =
2.917, df = 106, p ≤ 0.004; Figure 3B), but not in the 0–6 hpf
cortisol treatment group (Student’s t-test: t = 0.621, df = 89, ns;
Figure 3A), compared to the group treated with control medium
at 0–6 hpf. No effects were found for macrophage recruitment
for either 0–6 hpf cortisol treatment (Student’s t-test: t = 0.923,
df = 89, ns; Figure 3A) or 0–6 hpf dexamethasone treatment
(Student’s t-test: t =−1.095, df= 106, ns; Figure 3B).
Frontiers in Immunology | www.frontiersin.org 6 April 2020 | Volume 11 | Article 727
Van den Bos et al. Glucocorticoids Affect Immune-Function in Larvae
FIGURE 3 | (A) Number of neutrophils and macrophages (mean ± SEM) at 4 hpa for the different treatments (cortisol or control). (B) Number of neutrophils and
macrophages (mean ± SEM) at 4 hpa for the different treatments (dexamethasone or control). In both panels the picture illustrates the position of the site of the tail fin
amputation in 3 dpf larvae. **p = 0.01 (Student’s t-test).
LPS Exposure
Survival
In the LPS exposure experiments, we never observed any
morphological changes or mortality in the 4 dpf control groups.
Hence, we only present the data of the 4 dpf LPS-treated groups.
In the first LPS exposure experiment 27.8% of the 0–6 hpf
control-treated larvae survived after 28 h, while significantly
higher numbers of the 0–6 hpf glucocorticoid-treated larvae
survived after 28 h: cortisol: 89.5%, dexamethasone: 90.0%
(Figure 4A; Log Rank Mantel Cox, Chi-square = 20.863, df =
2, p < 0.001). Pair-wise comparisons revealed a significant effect
of cortisol vs. control, p < 0.001 (Log Rank Mantel Cox, Chi-
square= 14.385, df= 1) and a significant effect of dexamethasone
vs. control, p < 0.001 (Log Rank Mantel Cox; Chi-square =
12.436, df = 1). In the second LPS exposure experiment, which
served as replicate for the first LPS exposure experiment, 79.2%
of 0–6 hpf control-treated larvae survived after 24 h while a
strong tendency for higher numbers of 0–6 hpf glucocorticoid-
treated larvae survived after 24 h, in line with the first experiment:
cortisol: 100.0%, dexamethasone: 91.7% (Figure 4B; Log Rank
Mantel Cox, Chi-square = 5.824, df = 2, p ≤ 0.054). Pair-wise
comparisons revealed a significant effect for cortisol vs. control, p
≤ 0.019 (Log Rank Mantel Cox, Chi-square= 5.466, df= 1,) but
no significant effect for dexamethasone vs. control, ns (Log Rank
Mantel Cox, Log Rank Mantel Cox; Chi-square = 1.370, df= 1).
The latter may be related to the relatively high survival in control
subjects, precluding finding a significant effect.
Phenotypical Effects and Gene Expression
Endothelium-Related Genes
In the first LPS exposure experiment phenotypical changes were
measured at 4 and 28 h, i.e., 3.5 and 27.5 h after ending exposure.
Table 2 shows the numbers of dead larvae and of larvae that
were alive and displayed phenotypical changes. We observed
LPS-induced changes in the shape of the larvae (curved larvae),
tail fin morphology (swollen or damaged tail fins) and heart
cavity (oedema). Larvae were scored as either affected (at least
one of these changes present) or not (no changes in any of
the parameters). Supplementary Table 1 shows the scores of the
individual parameters at 4 h (the number of larvae of the control
treated group alive at 28 h was too low for a meaningful statistical
analysis between treatments).
While the scores at 4 h suggested that the LPS-induced
effects were less strong in glucocorticoid-treated larvae than in
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FIGURE 4 | (A) Per cent of surviving larvae following LPS treatment (from 0 to
0.5 h) and 0–6 hpf control treatment, cortisol treatment or dexamethasone
treatment in the first exposure series (time-points: 0, 4, and 28 h). (B) Per cent
of surviving larvae following LPS treatment (from 0 to 0.5 h) and 0–6 hpf control
treatment, cortisol treatment and dexamethasone treatment in second
exposure series (time-points: 0, 0.5, 1, 3, 6, and 24 h).
control-treated larvae, this was not (as yet) significant (Chi-
square = 5.81, df = 2, ns). LPS-induced effects were less
strong in glucocorticoid-treated larvae than in control-treated
larvae at 28 h (overall Chi-square = 25.33, df = 2, p < 0.001).
Pair-wise comparison showed that both cortisol-treated (Chi-
square = 18.05, df = 2, p < 0.001) and dexamethasone-treated
(Chi-square = 18.34, df = 2, p < 0.001) groups showed fewer
dead and fewer malformed larvae than control-treated subjects
following LPS exposure.
In addition to the phenotypical changes that we studied,
we measured expression levels of genes related to endothelial
barrier function (clnd5a, clnd2, and oclnb) in the first LPS
exposure experiment. Transcript abundance of clnd5awas higher
in cortisol-treated (Tukey HSD: p < 0.001) and dexamethasone-
treated larvae (Tukey HSD: p ≤ 0.067) compared to control-
treated larvae [two-way ANOVA; treatment and time as
independent factor; treatment: F(2, 36) = 9.815, p < 0.001;
Figure 5A]. Transcript abundance of clnd2 was lower in cortisol-
treated (Tukey HSD: p ≤ 0.034) and dexamethasone-treated
larvae (Tukey HSD: p ≤ 0.093) compared to control-treated
larvae [two-way ANOVA; treatment and time as independent
factor; treatment: F(2, 36) = 9.815, p < 0.001; Figure 5B]. At 3 h
transcript abundance of clnd2 was higher than at other time
points in all treatment groups (Tukey HSD; p < 0.001; time:
TABLE 2 | Per cent of larvae dead, alive and affected (regardless of phenotypical
changes in the tail fin, shape or cardiac area), and alive and intact at 4 and 28 h
after LPS treatment (0–0.5 h) in the different treatment groups: 0–6 hpf treatment
with control, cortisol-containing or dexamethasone-containing medium.
4h Treatment %Dead %(alive+affected)
(tail fin, shape, heart)
%(alive+intact)
Control (n = 18) 11.1 83.3 5.6




28h Treatment %Dead %(alive+affected)
(tail fin, shape, heart)
%(alive+intact)
Control (n = 15) 86.7 13.3 0.0




Note that the number of larvae at 28 h is lower than at 4 h; per treatment n = 3–4 larvae
(alive) were randomly selected for staining for reactive oxygen species in the tail fin (not
reported here); they were not scored for phenotypical changes.
F(2, 36) = 13.425, p < 0.001). Transcript abundance of oclnb
was lower in cortisol-treated and dexamethasone-treated larvae
than in control-treated larvae at baseline (0 h), but higher at 3 h
following LPS exposure [two-wayANOVA; treatment and time as
independent factor; treatment ∗time: F(3, 36) = 6.404, p < 0.001;
Figure 5C].
In the second LPS exposure experiment we measured changes
in tail fin morphology and shape as we hardly observed any
oedema in the heart cavity in the first LPS exposure experiment.
Figure 6 shows the changes in tail fin morphology following
LPS exposure. In control-treated larvae there was a clear and
rapid loss of normal tail fin structure and a shift toward
swollen or damaged tail fins, while this was not the case in the
glucocorticoid-treated larvae. Statistical analysis showed that at
3 h (Chi-square = 10.25, df = 4, p ≤ 0.036), 6 h (Chi-square =
10.27, df = 4, p ≤ 0.036) and 24 h (Chi-square = 10.25, df =
4, p ≤ 0.042) treatment groups differed significantly from one
another.More in particular, both cortisol-treated larvae (3 h: Chi-
square = 5.16, df = 2, p ≤ 0.076; 6 h: Chi-square = 6.94, df
= 2, p ≤ 0.03; 24 h Chi-square = 5.77, df = 2, p ≤ 0.056) and
dexamethasone-treated larvae (6 h: Chi-square = 6.98, df = 2,
p ≤ 0.03; 24 h Chi-square = 6.53, df = 2, p ≤ 0.038) showed
less severe changes in tail fin morphology than control-treated
larvae. We did not observe a strong effect of LPS exposure on
the shape of the larvae. After 24 h only small percentages of each
treatment group showed a curved shape: control-treated larvae
(see Supplementary Table 2 for all time points): 15.8% (n = 19);
cortisol-treated larvae: 8.3% (n = 24); dexamethasone-treated
larvae: 9.1% (n = 22); these differences were not significant
(Chi-square= 1.71, df= 2, ns).
Gene Expression Analysis
First, we explored the effects of glucocorticoid treatment through
the interrelationships of transcript abundance of genes using
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FIGURE 5 | (A) Transcript abundance (relative normalized expression; mean+SEM) of cldn5a following LPS treatment (from 0 to 0.5 h) and 0–6 hpf control treatment,
cortisol treatment or dexamethasone treatment (n = 4 samples per time-point). Groups with the same capitals do not significantly differ from one another (Tukey HSD
following a significant treatment effect for this time-point). Note: control-treated subjects showed no significant change over time: F (3, 12) = 2.009, ns. (B) Transcript
abundance (relative normalized expression; mean + SEM) of cldn2 following LPS treatment (from 0 to 0.5 h) and 0–6 hpf control treatment, cortisol treatment or
dexamethasone treatment (n = 4 samples per time-point). Note: control-treated subjects showed an increased expression at 3 h: F (3, 12) = 13.253, p < 0.001; Tukey
HSD. (C) Transcript abundance (relative normalized expression; mean + SEM) of oclnb following LPS treatment (from 0 to 0.5 h) and 0–6 hpf control treatment,
cortisol treatment or dexamethasone treatment (n = 4 samples per time-point). Groups with the same capitals do not significantly differ from one another (Tukey HSD
following a significant treatment effect for this time-point). Note: control-treated subjects showed no significant change over time: F (3, 12) = 0.562, ns.
PCA. Then in each component, we selected genes of interest
of which the transcript abundance of the different treatments
matched the differences in phenotypical changes and survival
that we observed between treatment groups. The following genes
(from the first LPS exposure experiment) were included in the
analysis: tlr2, tlr4ba, tlr4bb, tlr5a, tlr5b, il1β , myd88, il10, cxcr4a,
cxcr4b, and ptpn6.
A PCA revealed three components explaining in total 72.9%
of variance (Supplementary Table 3). The KMO was sufficiently
high (0.619) and Bartlett’s test of sphericity was highly significant
(Chi-square = 303.010, df = 55, p < 0.001) indicating that the
data were adequate for a PCA.
The first component, explaining 32.9% of the variance,
consisted of the genes of different Toll-like receptors: tlr2 (factor
loading: 0.677), tlr4ba (0.669), tlr4bb (0.764), tlr5a (0.779),
and tlr5b (0.838). The overall pattern of the factor regression
scores across time was an inverted U-shape: a two-way ANOVA
(independent factors: time and treatment) for this component
revealed a highly significant effect of time [F(3, 36) = 15.502,
p < 0.001] with time points 0 hr and 3 h having significantly
higher factor regression scores than time points 0.5 hr and
1 hr (Tukey HSD; Supplementary Table 3). Only weak effects
were found between the different treatments [F(2, 36) = 3.012,
p ≤ 0.062; F(6, 36) = 2.038, p ≤ 0.086]. The only gene of this
component of which the transcript abundance of the different
treatments seemed to match the differences in phenotypical
changes and survival was tlr4bb (see Supplementary Table 4 and
Figure 7A): transcript abundance increased less strongly over
time in glucocorticoid-medium treated subjects than in control-
medium treated subjects.
The second component, explaining 23.1% of the variance,
consisted of il1β (factor loading: 0.940), myd88 (0.844) and
il10 (0.758). As time progressed factor regression scores
increased [two-way ANOVA (independent factors: treatment
and time); time: F(3, 36) = 68.309, p < 0.001] with a post-
hoc Tukey HSD revealing that the factor regression scores
differed significantly from one another at all-time points
(Supplementary Table 3). The 0–6 hpf control group had
increasingly higher factor regression scores than the 0–6 hpf
cortisol treated group and the 0–6 hpf dexamethasone treated
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FIGURE 6 | (A) Per cent of larvae following LPS treatment (from 0 to 0.5 h) in the 0–6 hpf control treatment group showing normal, swollen, or damaged tail fins
(time-points: 0, 0.5, 1, 3, 6, and 24 h). (B) Per cent of larvae following LPS treatment (from 0 to 0.5 h) in the 0–6 hpf cortisol treatment group showing normal, swollen
or damaged tail fins (time-points: 0, 0.5, 1, 3, 6, and 24 h). (C) Per cent of larvae following LPS treatment (from 0 to 0.5 h) in the 0–6 hpf dexamethasone treatment
group showing normal, swollen, or damaged tail fins (time-points: 0, 0.5, 1, 3, 6, and 24 h).
group as time progressed [Supplementary Table 3; Tukey
HSD; treatment: F(2, 36) = 22.664, p < 0.001; treatment
∗time:
F(6, 36) = 13.491, p < 0.001]. Of all genes of this component,
transcript abundance of the different treatments seemed
to match the differences in phenotypical changes and
survival (Supplementary Table 4 and Figures 7B–D):
transcript abundance increased less strongly over time in
glucocorticoid-medium treated subjects than in control-medium
treated subjects.
The third component, explaining 16.9% of the variance,
consisted of regulators of the immune response: cxcr4a (factor
loading: 0.794), cxcr4b (0.809) and ptpn6 (0.799). Overall the
factor regression scores decreased over time: a two-way ANOVA
(independent factors: treatment and time) revealed a highly
significant effect of time [F(3, 36) = 4.464, p ≤ 0.009] with 3
and 0 h being significantly different from one another (Tukey
HSD). The 0–6 hpf dexamethasone treated group had lower
factor regression scores than the 0–6 hpf control treated group
and the 0–6 hpf cortisol treated group [treatment: F(2, 36) =
11.056, p < 0.001; treatment∗time: F(6, 36) = 5.571, p < 0.001).
The only gene of this component of which the transcript
abundance of the different treatments seemed to match the
differences in phenotypical changes and survival was cxcr4a (see
Supplementary Table 4 and Figure 7E): transcript abundance
increased in control-medium treated subjects but decreased in
glucocorticoid-medium treated subjects.
DISCUSSION
The data of this study showed that treatment of zebrafish
embryos with cortisol or dexamethasone during the first 6 h
after fertilization modulated the function of the immune system
and thereby enhanced survival after an immune challenge. This
suggests that in zebrafish maternal stress through enhancing
oocyte cortisol levels and thereby increased GR stimulation leads
to an adaptive response to immune challenges.
Baseline Expression of Immune-Related
Genes
Hartig et al. (21) have shown that 5-day exposure to (1µM)
cortisol in zebrafish embryos/larvae (0–5 dpf) enhanced baseline
expression of immune-related genes such as of socs3a, mpeg1,
and irg1l at 5 dpf. Here, we show that exposure at the first 6 h
of life (0–6 hpf) is already sufficient to induce enhanced baseline
expression of these genes at 5 dpf. As GR is the only corticosteroid
receptor present in these early life stages (3, 7, 8), this suggests
that activation of GR in these early stages is responsible for
mediating these effects. Indeed, we show that 0–6 hpf exposure
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FIGURE 7 | (A) Transcript abundance (relative normalized expression; mean+SEM) of tlr44bb following LPS treatment (from 0 to 0.5 h) and 0–6 hpf control treatment,
cortisol treatment or dexamethasone treatment (n = 4 samples per time-point). Groups with the same capitals do not significantly differ from one another (Tukey HSD
following a significant treatment effect for this time-point). (B) Transcript abundance (relative normalized expression; mean + SEM) of IL1β following LPS treatment
(from 0 to 0.5 h) and 0–6 hpf control treatment, cortisol treatment or dexamethasone treatment (n = 4 samples per time-point). Groups with the same capitals do not
significantly differ from one another (Tukey HSD following a significant treatment effect for this time-point). (C) Transcript abundance (relative normalized expression;
mean + SEM) of myd88 following LPS treatment (from 0 to 0.5 h) and 0–6 hpf control treatment, cortisol treatment or dexamethasone treatment (n = 4 samples per
time-point). Groups with the same capitals do not significantly differ from one another (Tukey HSD following a significant treatment effect for this time-point). (D)
Transcript abundance (relative normalized expression; mean+SEM) of IL10 following LPS treatment (from 0 to 0.5 h) and 0–6 hpf control treatment, cortisol treatment
or dexamethasone treatment (n = 4 samples per time-point). Groups with the same capitals do not significantly differ from one another (Tukey HSD following a
significant treatment effect for this time-point). (E) Transcript abundance (relative normalized expression; mean+SEM) of cxcr4a following LPS treatment (from 0 to
0.5 h) and 0–6 hpf control treatment, cortisol treatment or dexamethasone treatment (n = 4 samples per time-point). Groups with the same capitals do not
significantly differ from one another (Tukey HSD following a significant treatment effect for this time-point).
to the specific GR agonist dexamethasone enhanced baseline
expression of these immune-related genes in 5 dpf larvae as well.
This is in general agreement with data from studies showing that
exposure of embryos/larvae to other GR agonists (for variable
time-periods from fertilization) increased baseline expression of
(some of) these genes (42–44).
We have previously shown that 0–6 hpf exposure to
cortisol-containing medium enhanced baseline levels of cortisol
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compared to 0–6 hpf exposure to control medium at 5 dpf in
larvae of the AB strain, but not in larvae of the TL strain (10).
In addition, we have previously shown that 0–6 hpf exposure
to dexamethasone-containing medium did not change baseline
levels of cortisol compared to 0–6 hpf exposure to control-
medium at 5 dpf in larvae of the AB or TL strain (36). Overall
these data therefore strongly suggest that the effects on the
expression of immune-related genes in AB and TL larvae are not
related to changes in baseline levels of cortisol.
While we have previously observed substantial differences
between larvae of the AB and TL strains in gene expression,
physiology and behavior (10, 22–24), the effects of 0–6 hpf
exposure to cortisol and dexamethasone on baseline expression
of immune-related genes were similar in both strains. This
suggests a robust strain-independent effect.
Tail Fin Amputation Assay
It has been shown that tail fin amputation in 3 dpf larvae leads
to a rapid recruitment of macrophages (within 2 hpa) remaining
at a plateau for at least 24 h thereafter, while the number of
neutrophils reaches a peak 4 hpa declining thereafter (30).
Here, we observed that dexamethasone increased the number
of neutrophils at 4 hpa, while it had no effect on the number
of macrophages at 4 hpa. These data suggest that pre-exposed
subjects mount a stronger response to injury, possibly enhancing
protection against invading micro-organisms (26).
Dexamethasone, but not cortisol, exposure was effective in
increasing the recruitment of neutrophils. Two explanations
may be forwarded for this. First, this may be related to
dexamethasone’s higher affinity for GR (25). In line with this
we observed enhanced expression of FK506 binding protein
5 (fkbp5), a marker for levels of GR stimulation [e.g., (42,
43)] in dexamethasone-exposed embryos, but not cortisol-
exposed embryos (10, 36). Second, it has been shown neutrophil
recruitment, but not macrophage recruitment, is sensitive to
acute treatment with GR agonists, including cortisol, which
decreases the number of neutrophils at 4 hpa (26, 30, 31).
We have observed that baseline levels of cortisol are enhanced
following cortisol but not dexamethasone treatment (10, 36).
Hence, in the case of cortisol pre-exposure enhancement of
neutrophil recruitment through GR stimulation (as indicated by
the effect of dexamethasone) may potentially be offset at 3 dpf
by the higher baseline levels of cortisol. If so, this suggests a
fine-tuning of the response. Future studies should address these
alternative explanations.
LPS Challenge
In line with results from other studies (32–35) LPS exposure
produced phenotypical changes (tail fin oedema, swollen or
damaged tail fins, and curved animals), mortality and increased
expression levels of immune-related genes. To assess the
molecular mechanisms underlying the effects of LPS exposure,
we measured the expression of cldn5a, cldn2, and oclnb;
genes of which the expression has been shown to be changed
following LPS exposure (33, 35) and which are involved in
endothelial barrier function (45–48). The strong increase in the
expression of cldn2 at 3 h in control-treated subjects is in line
with data from other studies (33, 35). Increased expression of
cldn2 is associated with endothelial hyper-permeability due to
increased pore-pathway activity possibly mediated by increased
expression of IL-13 (45–48). At variance with other studies
(33, 35) we did not observe strongly decreased expressions
of cldn5a and oclnb. Decreased expression levels of cldn5a
and oclnb are related to endothelial hyper-permeability due
a lower sealing function of the pore-pathway and a less
functional leaky pathway, respectively (45–48). One reason for
this may be that we measured gene expressions at 3 h after
the start of the LPS exposure, while in other studies this was
measured at substantially later time points, i.e., 6 and 8 h (33,
35).
In both LPS exposure experiments both cortisol and
dexamethasone exposure at 0–6 hpf were associated with
milder effects to LPS compared to control exposure at 0–
6 hpf, indicating a robust effect of glucocorticoid exposure.
This was expressed as milder phenotypical changes (lower
number of larvae expressing tail fin oedema, damaged tail
fins or curved animals), lower mortality, and lower gene
expression of immune-related genes, such as il1β . As to the
expression of endothelium-related genes we noted that the
expression of cldn5a was higher and expression of cldn2 lower
in cortisol- and dexamethasone-treated subjects compared to
control-treated subjects. This suggests a lower permeability of
the endothelium due to a lower pore-pathway activity (45–
48) supporting the milder phenotypical effects following LPS
exposure. The expression of oclnb was strongly increased after
3 h in 0–6 hpf cortisol-treated and dexamethasone-treated
subjects compared to control-treated subjects. This suggests
lower permeability due to more protective leaky pathway activity
(45–48). It has been shown that 24 h following LPS challenge in
zebrafish larvae the expression of oclnb is strongly up-regulated
facilitating tissue-repair (33). Again, the data support the milder
phenotypical effects that we see following LPS exposure in
cortisol-treated and dexamethasone-treated subjects compared
to control-treated subjects.
To explore the underlying mechanisms of glucocorticoid
treatment we measured the expression of a series of genes of
interest and related their expression to the outcome of the
phenotypical changes and mortality. Five genes stood out in
this respect, reflecting two receptors (tlr4bb and cxcr4a), a
factor involved in the transduction pathway of the expression of
cytokines (myd88) and two cytokines (il1β and il10).
While LPS exerts its effects through transduction mechanisms
following binding to TLR4 in mammals (45, 49), in zebrafish
this is not clear as yet: tlr4ba and tlr4bb have been suggested
to be paralogues rather than homologs and TLR4BA and
TLR4BB have thus far not been shown to be activated
by LPS possibly by lack of a binding site for LPS (50,
51). However, TLR4BB has been shown to be involved
in inflammatory processes as tlr4bb transcript abundance is
increased following tail fin amputation (30). Here, we observed
an increase in tlr4bb expression in 0–6 hpf control-treated
subjects over time, accompanied by a strong inflammatory
response, which was less strong in 0–6 hpf cortisol-treated
or dexamethasone-treated subjects, accompanied by a milder
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inflammatory response. This suggests a role for TLR4BB in the
LPS-induced response.
In humans CXCR4 has been implicated in recognition of LPS
or being part of a “LPS sensing apparatus” in addition to TLR4
(52, 53). Furthermore, LPS increases the expression of cxcr4
through an NF-κB signaling pathway associated with increased
micro-vascular leakage in the lungs (54) or increased colorectal
tumor metastasis (55). Here, we observed an increase in cxcr4a
expression in 0–6 hpf control-treated subjects over time, which
was absent in 0–6 hpf cortisol-treated or dexamethasone-treated
subjects. This difference in gene expression may be associated
with differences in the extent of vascular leakage as suggested
by the differences in the expression of genes involved in the
endothelial barrier and differences in tail fin oedema between
treatments as discussed above. In zebrafish cxcr4a is found in
endothelial cells (blood vessels), while cxcr4b is not (56), which
may explain that we only observed a phenotype-related effect for
the expression profile of cxcr4a. Interestingly, CXCR4 has been
implicated in the development of tolerance to lethal doses of LPS
in zebrafish larvae (32, 34). Thus, this suggests that CXCR4 is
involved in modulating the response to LPS.
Overall therefore our data warrant further studies into the role
of TLR4BB and CXCR4 in LPS-induced sepsis in zebrafish as well
as into the effects of early life glucocorticoid stimulation hereon.
Earlier studies have shown that MYD88 knockout larvae show
enhanced survival to LPS challenge (33) and no increase in il1β
expression (57). Lethal, but not sub-lethal, doses of LPS have
been found to be associated with high expression levels of il1β
and il10 in zebrafish larvae, indicative of a hyper-inflammatory
response (32). In line with these findings we observed that the
expression levels ofmyd88, il1β, and il10 were strongly increased
3 h after LPS challenge associated with low survival in 0–6 hpf
control-treated subjects, but lower levels of expression of all
three genes with higher survival in 0–6 hpf cortisol-treated and
dexamethasone-treated subjects. Myd88 is an adaptor protein
critical to toll-like receptor signaling [except for TLR3; (49)]
and IL1β receptor signaling [see (38, 57)] and thereby cytokine
expression. It should be noted thatmyd88 expression was already
low in 0–6 hpf cortisol-treated and dexamethasone-treated
subjects, suggesting lower transduction pathway activity, possibly
leading to a lower stimulation of inflammatory pathways. It is
clear that this deserves further study.
As indicated above following cortisol or dexamethasone
treatment at 0–6 hpf we noted increased base-line expression
levels of irg1l, socs3a, mpeg1.1, and mpeg1.2 compared
to control treatment at 0–6 hpf. These increased base-
line levels may aid in increased clearance of bacteria and
preventing excessive inflammation and hence aid in increasing
survival (26, 58, 59).
The data of LPS exposure in larvae observed here seem
to match the data of LPS exposure in adult zebrafish
following 0–5 dpf exposure to cortisol: LPS exposure did
not increase il1β expression in different tissues measured
(21). Unfortunately no survival was measured in the
latter study.
Overall these data suggest that the response to LPS of subjects
pre-exposed to cortisol or dexamethasone is less strong than
the response of subjects of pre-exposed to control medium.
How differences in survival, phenotype and gene-expression
levels are causally related remains to be studied. As we have
observed in larvae of the AB strain that 0–6 hpf exposure
to cortisol increased baseline levels of cortisol at 5 dpf, while
0–6 hpf exposure to dexamethasone did not change baseline
levels of cortisol at 5 dpf (10, 36), the data suggest that
these effects are not related to changes in baseline levels
of cortisol.
Limitations
A clear limitation is that we only used one dose of cortisol and
dexamethasone. For convenience we used equimolar doses of
cortisol and dexamethasone, which may have led to different
levels of stimulation of GR 0–6 hpf. Thus, in future studies
different dose-ranges may be warranted, e.g., to study whether
higher concentrations of cortisol in the tail fin amputation
assay have an effect on neutrophil recruitment, and to assess
whether higher doses have similar protective effects in the LPS-
exposure paradigm.
Regarding the tail fin amputation assay it has been shown
that glucocorticoids may play a role in the differentiation of
macrophages into a pro-inflammatory (M1) phenotype (31). So,
future studies should study in more detail the effects of early
life exposure of glucocorticoids on the inflammatory response
and wound healing. Similarly, we used LPS to induce a hyper-
inflammatory response, i.e. sepsis (33, 35), as a model to study the
effectiveness of our early life treatments. To assess the ecological
relevance of our findings and their more general nature the effects
of early-life exposure on larval exposure to different pathogens,
such as of bacterial, viral or fungal origin, should be studied [see
e.g., (12, 57)].
While the effects of 0–6 hpf glucocorticoid treatment appeared
to be similar in both LPS exposure experiments, the effects of
0–6 hpf control treatment seemed to differ, i.e., in the second
experiment more subjects survived than in the first experiment.
This highlights the value of and need for biological replication.
We predict therefore that this would also be reflected in the
expression of endothelium-related and immune-related genes in
control subjects in the second experiment, i.e., the differences
between control treatment and glucocorticoid treatment would
be less strong. In future experiments therefore we will routinely
analyse a number of key genes alongside phenotypical changes.
As to the observation that control-treated larvae showed variable
responses, this is not uncommon as we also observed variable
responses in other immune-related paradigms such as the
response to a dextran sodium sulfate (DSS) challenge (Van den
Bos et al., unpublished observations). While as yet speculative
differences in baseline levels of expression of il1β may be one
associated factor as we observed that higher baseline levels
seem associated with milder responses to LPS (Van den Bos
et al., unpublished data). This is not unprecedented as this
has also been observed in mice: enhanced levels of IL1 are
associated with a milder response to LPS (60). It has been
shown that following hatching il1β expression increases due
to exposure to microbes in the medium (61). This tunes the
activity of the innate immune system of the zebrafish larvae and
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determines thereby their disease resistance. In the laboratory
however this may lead to variation between experimental series
as the microbial load of the mediummay vary from experimental
series to series. It is clear that this warrants further studies.
It has been suggested that tuning the innate immune system
occurs through chromatin modifications [see e.g., (61–64)].
Our future studies are directed at understanding the variable
responses in this context. In addition our future studies are
directed at understanding how 0–6 hpf glucocorticoid treatment
affects this as we do not observe such variation following
this treatment.
The immune system affects HPI-axis activity and vice versa
(1). However, we did not address changes in HPI-axis activity
as a consequence of our procedures (tail fin amputation or
LPS exposure) in this study as the primary aim was to study
whether our pre-treatments would affect immune function. Still
changes in HPI-axis activity may be anticipated. For example, a
recent study showed in European sea bass (Dicentrarchus labrax)
larvae 5 day post-hatching that at 120 h following infection
with the bacterium Vibrio anguillarum, when mortality was
already high, HPI-axis activity increased (65). This increased
activity coincided with increased expression of pro-inflammatory
and anti-inflammatory genes. While the underlying mechanism
was not clear as yet, the data show that infections may
impact HPI-axis activity. It has been shown that early-life
exposure to cortisol dampens the response of the HPI-axis
to stressors in zebrafish larvae (15). Hence, future studies
should address how early-life exposure to cortisol affects the
relationship between immune function and HPI-axis activity,
and how this relates to the increased survival that we have
observed here.
We have used 0–6 hpf cortisol exposure by the medium
as a model or proxy of increased oocyte levels of cortisol
due to chronic stress in mothers (10), while others have
used micro-injection of cortisol in the yolk of single-cell
stage embryos (13–15). Chronic stress, whether due to
excessive predation, food shortage, crowding or out-of-
range-temperatures, is associated with increased levels of
cortisol (1) and at this level these procedures may be a
valid approach of mimicking maternal stress. Still, these
different stressors may have additional neuro-endocrine and/or
metabolic signatures that affect oocyte yolk-sac contents and
hence thereby development of embryos and larvae. Thus,
future experiments should compare the present data with
data from chronically stressed mothers using different types
of stressors. In addition, future experiments should assess
whether a paternal contribution exists by subjecting fathers to
chronic stress.
CONCLUSION
These data show that early-life exposure to cortisol, as a
model or proxy of maternal stress, induces an adaptive
response to immune challenges, which seems mediated via the
glucocorticoid receptor.
These data are of relevance for both ecological research
(66) and biomedical research (18) in understanding
the effects of stressful conditions and exposure to
endocrine disruptors on disease susceptibility and
survival of offspring. Future studies should elucidate
whether the effects also hold in subjects of other strains
than AB revealing thereby fundamental aspects of how
early-life levels of cortisol affects offspring functioning
and survival.
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